Hofseth Biocare ASA: NESTLÉ GARDEN OF LIFE LAUNCHES HBC OMEGO® FULL SPECTRUM OMEGAS IN THE US

05 May 2025 14:19 CEST

Nestlé-owned Garden of Life has launched OmeGo® Full Spectrum Omegas on Amazon
in the US. Branded as "Norwegian Salmon Oil", it retains the complete balance
and nutritional profile of fresh Atlantic salmon in a softgel format.

Joining Garden of Life's portfolio of health supplements available online,
Norwegian Salmon Oil containing OmeGo® is gently liberated from fresh, sashimi-
grade salmon and provides whole-fish health benefits from its full spectrum of
omegas. It differentiates from a competitive Omega-3 market that is more focused
on two fatty acids (EPA and DHA). In contrast, OmeGo® is direct and sustainable
from "fjord to shore" and provides Omegas 3, 5, 6, 7, 9 and 11, as well as other
mediators promoting anti-inflammatory and antioxidant benefits to human health.

HBC has recently published scientific findings on the powerful natural anti-
inflammatory benefits of OmeGo® for immune health, allergies and sleep quality
following successful low dose clinical studies.

For further information, please contact:
James Berger, Chief Commercial Officer of Hofseth BioCare ASA
Phone: +41 799501034
E-mail: jb@hofsethbiocare.com

About Hofseth BioCare ASA:

Hofseth BioCare is a Norwegian consumer and pet health company founded on the
core values of sustainability, optimal utilization of natural resources and full
traceability. It upcycles the side streams of the salmon industry by taking
fresh filleted salmon and converting it from a waste product into ingredients to
improve human and pet health. These ingredients are ProGo®, a mix of bioactive
peptides and collagen, OmeGo®, a whole salmon oil, with all the fatty acid
fractions contained in fish, and CalGo® / NT-II(TM) salmon bone powder
containing
calcium hydroxyapatite and undenatured collagen for bone and joint health.

HBC places scientific evidence at the forefront which has led to important
academic partnerships and the identification of unique health benefits. This
includes the demonstration of improved iron metabolism by boosting the body's
ability to take up and use iron resulting in increased energy and vitality with
ProGo® as well as the activation of the GLP-1 receptor with fat reduction in
overweight adults. OmeGo® has shown important immune health benefits including
recovery from viral infection and improved respiratory health and sleep in
adults troubled by particulate matter pollution. Finally, CalGo® has shown both
bone and joint health benefits to support healthy ageing and active lifestyles.
This work has also resulted in the granting of a number of patents protecting
these discoveries. It has also led to the discovery of potential therapeutics
and HBC has spun out a biotech-focused company, HBC Immunology (HBCI). HBCI has
raised external finance, and the lead program is in prostate cancer followed by
ovarian cancer. A separate molecule is targeted as an oral, steroid-sparing
therapy for asthma.

More information:
Access the news on Oslo Bors NewsWeb site